POM (Pomdoctor) Notes Receivable: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

POM Pomdoctor Ltd POM
20 GF Score
Price $1.02
! 7 Warning Signs
View Full Analysis

What is Pomdoctor Notes Receivable?

Pomdoctor POM +4.66% 20 Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus rates POM with a GF Score™ of 20/100. The stock has 7 warning signs investors should review.

Pomdoctor's Notes Receivable for the quarter that ended in Dec. 2025 was $0.00 Mil.

Pomdoctor Notes Receivable Historical Data

* Premium members only.

The historical data trend for Pomdoctor's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pomdoctor Notes Receivable Chart

Pomdoctor Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Pomdoctor Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
POM
20GF Score
Pomdoctor Ltd POM
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pomdoctor Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Pomdoctor (POM) has a Notes Receivable of $0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Pomdoctor and its competitors.
Is Pomdoctor's Notes Receivable too high?
Pomdoctor's current Notes Receivable is $0.00 Mil. Overall, Pomdoctor has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Pomdoctor's Notes Receivable compare to BLMH and HEWA?
Pomdoctor's Notes Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Pomdoctor and its competitors. Pomdoctor's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pomdoctor stock overvalued right now?
Pomdoctor (POM) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Pomdoctor's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Pomdoctor (POM), the current Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pomdoctor Business Description

Address No.19-23 Hejing Road, Dongsha Street, Yongxu Industrial Park, Liwan District, Guangzhou, CHN, 510000
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.
20GF Score

Get the complete analysis for POM

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.02
Price